Toward clinical application of prompt gamma spectroscopy forin vivomonitoring of boron uptake in boron neutron capture therapy

2001 ◽  
Vol 28 (5) ◽  
pp. 787-795 ◽  
Author(s):  
P. M. Munck af Rosenschöld ◽  
W. F. A. R. Verbakel ◽  
C. P. Ceberg ◽  
F. Stecher-Rasmussen ◽  
B. R. R. Persson
2014 ◽  
Vol 16 (suppl 2) ◽  
pp. ii67-ii67
Author(s):  
A. Detta ◽  
G. C. Cruickshank ◽  
S. Green ◽  
N. P. Lockyer ◽  
D. Ngoga ◽  
...  

2016 ◽  
Vol 43 (6Part35) ◽  
pp. 3757-3757
Author(s):  
S Kim ◽  
T Suh ◽  
D Yoon ◽  
J Jung ◽  
H Shin ◽  
...  

2011 ◽  
Vol 69 (2) ◽  
pp. 394-398 ◽  
Author(s):  
S. Bortolussi ◽  
J.G. Bakeine ◽  
F. Ballarini ◽  
P. Bruschi ◽  
M.A. Gadan ◽  
...  

2020 ◽  
Vol 61 (4) ◽  
pp. 524-534
Author(s):  
Takaomi Harada ◽  
Katsumi Hirose ◽  
Yuki Wada ◽  
Mariko Sato ◽  
Koji Ichise ◽  
...  

Abstract The uptake of boron into tumor cells is a key factor in the biological effects of boron neutron capture therapy (BNCT). The uptake of boron agents is suppressed in hypoxic conditions, but the mechanism of hypoxia-induced modulation of suppression of boron uptake is not clear. Therefore, we evaluated whether hypoxia-inducible factor 1α (HIF-1α) contributes to attenuation of the antitumor effects of BNCT in hypoxic tumor cells. We also tested whether YC-1, a HIF-1α-targeting inhibitor, has therapeutic potential with BNCT. To elucidate the mechanism of attenuation of the effects of BNCT caused by hypoxia, deferoxamine (DFO) was used in experiments. Cells were incubated in normal oxygen, hypoxic conditions (1% O2) or 5 μM DFO for 24 h. Then, cells were treated with 10B-boronophenylalanine (BPA) for 2 h and boron accumulation in cells was evaluated. To clarify the relationship between HIF-1α and L-type amino acid transporter 1 (LAT1), gene expression was evaluated by a using HIF-1α gene knockdown technique. Finally, to improve attenuation of the effects of BNCT in hypoxic cells, BNCT was combined with YC-1. Boron uptake was continuously suppressed up to 2 h after administration of BPA by 5 μM DFO treatment. In cells treated with 5 μM DFO, LAT1 expression was restored in HIF-1α-knocked down samples in all cell lines, revealing that HIF-1α suppresses LAT1 expression in hypoxic cells. From the results of the surviving fraction after BNCT combined with YC-1, treatment with YC-1 sensitized the antitumor effects of BNCT in cells cultured in hypoxia.


2014 ◽  
Vol 42 (1) ◽  
pp. 165-169 ◽  
Author(s):  
Do-Kun Yoon ◽  
Joo-Young Jung ◽  
Key Jo Hong ◽  
Keum Sil Lee ◽  
Tae Suk Suh

2015 ◽  
Vol 42 (7) ◽  
pp. 4161-4173 ◽  
Author(s):  
R. O. Farías ◽  
M. A. Garabalino ◽  
S. Ferraris ◽  
J. Santa María ◽  
O. Rovati ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document